Corrigendum to "Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease" [Atherosclerosis 234 (2) (2014) 270-275] DOI: 10.1016/j.atherosclerosis.2014.03.001;Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 270-275

  Sinn, Dong Hyun ^a,b   Gwak, Geum Youn ^a   Cho, Juhee ^c,d   Son, Hee Jung ^a   Paik, Yong Han ^a   Choi, Moon Seok ^a   Lee, Joon Hyeok ^a   Koh, Kwang Cheol ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Inje University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alcohol consumption; Cardiovascular disease; Carotid artery stenosis; Carotid plaques; Nonalcoholic fatty liver disease

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; ECHOGRAPHY; HUMAN; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ATHEROSCLEROTIC PLAQUE; CAROTID STENOSIS; CHI SQUARE DISTRIBUTION; DRINKING BEHAVIOR; LIVER CIRRHOSIS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTECTION; RISK; RISK FACTOR; SEX DIFFERENCE; SOUTH KOREA; STATISTICAL MODEL;

ADULT; ALCOHOL DRINKING; CAROTID STENOSIS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; PROTECTIVE FACTORS; REPUBLIC OF KOREA; RISK FACTORS; SEX FACTORS;

EID: 84900868047     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.05.006     Document Type: Erratum

References (29)

1. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012, 142(7):1592-1609.
2. Chitturi S., Wong V.W., Farrell G. Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. JGastroenterol Hepatol 2011, 26(Suppl.1):163-172.
3. Park S.H. Current status of liver disease in Korea: nonalcoholic fatty liver disease. Korean J Hepatol 2009, 15(Suppl.6):S34-S39.
4. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332(6037):1519-1523.
5. Del Ben M., Baratta F., Polimeni L., Angelico F. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Intern Emerg Med 2012, 7(Suppl.3):S291-S296.
6. Lazo M., Hernaez R., Bonekamp S., Kamel I.R., Brancati F.L., Guallar E., et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011, 343. d6891.
7. Calori G., Lattuada G., Ragogna F., Garancini M.P., Crosignani P., Villa M., et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011, 54(1):145-152.
8. Carnevale R., Nocella C. Alcohol and cardiovascular disease: still unresolved underlying mechanisms. Vasc Pharmacol 2012, 57(2-4):69-71.
9. Thun M.J., Peto R., Lopez A.D., Monaco J.H., Henley S.J., Heath C.W., et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. NEngl J Med 1997, 337(24):1705-1714.
10. Cicorella N., Zanolla L., Franceschini L., Cacici G., De Cristan B., Arieti M., et al. Usefulness of ultrasonographic markers of carotid atherosclerosis (intima-media thickness, unstable carotid plaques and severe carotid stenosis) for predicting presence and extent of coronary artery disease. JCardiovasc Med (Hagerstown) 2009, 10(12):906-912.
11. Kozakova M., Palombo C., Eng M.P., Dekker J., Flyvbjerg A., Mitrakou A., et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology 2012, 55(5):1406-1415.
12. Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. JAm Soc Echocardiogr 2008, 21(2):93-111. quiz 89-90.
13. Roh Y.N., Woo S.Y., Kim N., Kim S., Kim Y.W., Kim D.I. Prevalence of asymptomatic carotid stenosis in Korea based on health screening population. JKorean Med Sci 2011, 26(9):1173-1177.
14. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detectionof hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986, 292(6512):13-15.
15. Hernaez R., Lazo M., Bonekamp S., Kamel I., Brancati F.L., Guallar E., et al. Diagnostic accuracy reliability ultrasonography detection fatty liver: meta-analysis. Hepatology 2011, 54(3):1082-1090.
16. Angulo P., Hui J.M., Marchesini G., Bugianesi E., George J., Farrell G.C., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007, 45(4):846-854.
17. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752.
18. Lee S.G., Park H.S., Kim S.M., Kwon H.S., Kim D.Y., Kim D.J., et al. Cut-off points of waist circumference for defining abdominal obesity in the korean population. Korean J Obes 2006, 1(20):23-30.
19. King D.E., Mainous A.G., Geesey M.E. Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events. Am J Med 2008, 121(3):201-206.
20. Liangpunsakul S., Chalasani N. What should we recommend to our patients with NAFLD regarding alcohol use?. Am J Gastroenterol 2012, 107(7):976-978.
21. Suzuki A., Angulo P., St Sauver J., Muto A., Okada T., Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007, 102(9):1912-1919.
22. Dunn W., Sanyal A.J., Brunt E.M., Unalp-Arida A., Donohue M., McCullough A.J., et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). JHepatol 2012, 57(2):384-391.
23. Moriya A., Iwasaki Y., Ohguchi S., Kayashima E., Mitsumune T., Taniguchi H., et al. Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011, 33(3):378-388.
24. Gunji T., Matsuhashi N., Sato H., Fujibayashi K., Okumura M., Sasabe N., et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 2009, 104(9):2189-2195.
25. Gunji T., Sato H., Iijima K., Fujibayashi K., Okumura M., Sasabe N., et al. Modest alcohol consumption has an inverse association with liver fat content. Hepatogastroenterology 2012, 59(120):2552-2556.
26. Gunji T., Matsuhashi N., Sato H., Iijima K., Fujibayashi K., Okumura M., et al. Alcohol consumption is inversely correlated with insulin resistance, independent of metabolic syndrome factors and fatty liver diseases. JClin Gastroenterol 2011, 45(9):808-813.
27. Dunn W., Xu R., Schwimmer J.B. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008, 47(6):1947-1954.
28. Ascha M.S., Hanouneh I.A., Lopez R., Tamimi T.A., Feldstein A.F., Zein N.N. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010, 51(6):1972-1978.
29. Hernaez R., Lazo M., Bonekamp S., Kamel I., Brancati F.L., Guallar E., et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011, 54(3):1082-1090.